2024, Number 02
<< Back Next >>
Ginecol Obstet Mex 2024; 92 (02)
Uterine artery ligation for prevention of postpartum hemorrhage in patients with risk factors for cesarean section
Nucamendi SE, Chávez RJM, Long MNJ, Hernández GLE, López CSA
Language: Spanish
References: 29
Page: 52-59
PDF size: 204.63 Kb.
ABSTRACT
Objective: Evaluation of the benefits and harms of bilateral uterine artery ligation for
prevention of postpartum hemorrhage in patients with risk factors.
Material and Method: Prospective, experimental, randomized, case-control,
longitudinal, comparative study conducted during 2022, which included patients
with risk factors for postpartum hemorrhage who terminated pregnancy by emergency
cesarean section. Two groups were included: the experimental group, in which the
technique of bilateral uterine artery ligation was applied, and the control group, in
which only cesarean section was performed. Before and after the surgical procedure,
blood loss, hemoglobin and hematocrit parameters were estimated and compared
with the control group.
Results: Ninety-one patients were studied: 45 in the experimental group and 46 in
the cesarean only group. Significant differences were observed in blood loss in the
experimental group (345.56 ± 64.69 mL) compared to the control group (426.06 ±
125.49 mL; p = 0.000247), in hemoglobin (experimental group: 11:13 ± 1.62 g/dL;
control group: 10.49 ± 1.32 g/dL, p = 0.037) and hematocrit (experimental group:
33.86%; control group: 31.87%; p = 0.017).
Conclusion: Bilateral uterine artery ligation in patients with risk factors for postcesarean
hemorrhage is an effective preventive measure that helps to reduce blood
loss. When combined with uterotonics, it reduces the volume of bleeding.
REFERENCES
Organización Panamericana de la Salud-Organización Mundialde la Salud. Cero muertes maternas por hemorragia.OPS-OMS 2023. https://www.paho.org/es/cero-muertesmaternas-por-hemorragia.
Observatorio de Mortalidad Materna. OMM 2022. https://omm.org.mx/sistema-de-indicadores/boletines/
Recomendaciones de la OMS para la prevención y eltratamiento de la hemorragia posparto. OrganizaciónMundial de la Salud. 2014.https://apps.who.int/iris/bitstream/handle/10665/141472/9789243548500_spa.pdf;jsessionid=394DBF24CE461B149A6B9E82CBB2C197?sequence=1
Schlembach D, Mörtl MG, Girard T, Arzt W, Beinder E,Brezinka C, et al. Management of postpartum hemorrhage(PPH) Algorithm of the interdisciplinary DA-CH consensusgroup PPH (Germany-Austria-Switzerland). Anaesthesist2014; 63: 234-42. doi.10.1007/s00101-014-2291-1
Prevención y manejo de la hemorragia postparto. Guía dePráctica Clínica: Evidencias y Recomendaciones. México.Centro Nacional de Excelencia Tecnológica en Salud. CENETEC.2021. http://www.cenetecdifusion.com/CMGPC/GPC-SS-103-21/ER.pdf
Lalonde A; International Federation of Gynecology and Obstetrics.Prevention and treatment of postpartum hemorrhagein low‐resource settings. Int J Gynaecol Obstet 2012;117 (2): 108-8. doi:10.1016/j.ijgo.2012.03.001
Rueda Monsabe A, Sanabria-Castelblanco JE, Montañez-Aldana MA. Manejo de la hemorragia posparto en unapaciente con útero bicorne con la sutura B-Lynch. Reportede caso y revisión de la literatura. Revista Colombianade Obstetricia y Ginecoogía 2023; 74:2. doi:10.18597/rcog.3989
Butwick AJ, Carvalho B, Blumenfeld YJ, El-Sayed YY,Nelson LM, Bateman BT. Second-line uterotonics andthe risk of hemorrhage-related morbidity. Am J ObstetGynecol 2015; 212 (5): 642.e1-642.e6427. doi:10.1016/j.ajog.2015.01.008
Kuwabara M, Takahashi Y, Iwagaki S, et al. Effectivenessof preventive B-Lynch sutures in patients at a high risk ofpostpartum hemorrhage. J Obstet Ginecol Research 2022;(48): 12: 3111-3118. doi:10.1111/jog.15415
Wetta L A, Szychowski JM, Seals S, Mancuso MS, BiggioJR, & Tita AT. Risk factors for uterine atony/postpartumhemorrhage requiring treatment after vaginal delivery.Am J Obstet Gynecol 2013; 209 (1): 51.e1-51. e516.doi:10.1016/j.ajog.2013.03.011
Stones RW, Paterson CM, Saunders NJ. Risk factors formajor obstetric haemorrhage. Eur J Obstet Gynecol ReprodBiol 1993; 48: 15-18. doi:10.1016/0028-2243(93)90047-g
Liu CN, Yu FB, Xu YZ, Li JS, Guan ZH, Sun MN, et al. Prevalenceand risk factors of severe postpartum hemorrhage: aretrospective cohort study. BMC Pregnancy and Childbirth2021; 21 (1): 332. doi:10.1186/s12884-021-03818-1
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, GülmezogluAM, Temmerman M, Alkema L. Global causes of maternaldeath: a WHO systematic analysis. Lancet Glob Health2014; 2 (6): e323-33. doi:10.1016/S2214-109X(14)70227-X
Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology,risk factors, and causes. Clin Obstet Gynecol 2010; 53(1): 147-56. doi:10.1097/GRF.
Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalenceand risk factors of severe obstetric haemorrhage.BJOG 2008; 115 (10): 1265-72. doi:10.1111/j.1471-0528.2008.01859.x
Ende HB, Lozada MJ, Chestnut DJ, et al. Risk factors foratonic postpartum hemorrhage: a systematic reviewand meta-analysis. Obstet Gynecol 2021; 137: 305-23.doi:10.1097/AOG.0000000000004228
García-Espinosa M, Martínez-Torres JA, Caldiño-Soto F.Ligadura de arterias hipogástricas previo al alumbramientoo a la histerectomía obstétrica modificada en inserciónanómala de placenta. Ginecol Obstet Méx 2022; 90 (11):869-85. doi.10.24245/gom.v90i11.7910.
Lynch BC, Coker A, Lawal AH, Abu J, et al. The BLynchsurgical technique for the control of massivepostpartum haemorrhage: an alternative to hysterectomy?Five cases reported. BJOG 1997; 104 (3): 372-75.doi:10.1111/j.1471-0528.1997.tb11471.x
Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonaldS. Prophylactic use of oxytocin in the third stage oflabour. Cochrane Database Syst Rev 2001; (4): CD001808.doi:10.1002/14651858.CD001808
McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage oflabour. Cochrane Database Syst Rev 2004; (1): CD000201.doi:10.1002/14651858.CD000201.pub2
Allam MS, B-Lynch C. The B-Lynch and other uterine compressionsuture techniques. Int J Gynaecol Obstet 2005;89: 236-41.doi:10.1016/j.ijgo.2005.02.014
Posadas-Nava A, Moreno-Santillán, Celis-González C, &Cruz-Martínez, E. Control de la hemorragia obstétrica medianteligadura selectiva de las arterias uterinas. Experienciade siete años. Ginecol Obstet Mex 2019; 87 (9): 576-82.doi: 10.24245/gom. v87i9.2946
Posadas-Nava A, Moreno-Santillán AA, Celis-GonzálezC, et al. Control efectivo de la hemorragia obstétricaposparto mediante desarterialización selectiva uterina.Descripción de la técnica Posadas. Ginecol Obstet Mex2016; 84 (12): 808-813. https://ginecologiayobstetricia.org.mx/download/1183
Villegas-Arias MA, Toro-Ortiz JC, Hernández-Rodríguez HG,Fernández-Lara JA. Balón de Bakri en el control de la hemorragiaobstétrica. Experiencia de cinco años. Ginecol ObstetMex 2022; 90 (10): 809-18. doi:10.24245/gom.v90i10.3145.
Refaie W, Fawzy M, Shabana A. Prophylactic bilateralinternal iliac artery ligation for management of low-lyingplacenta accreta: a prospective study. Tanta Med J 2014;42:146-50. doi:10.4103/1110-1415.145278
Sanad AS, Mahran AE, Aboulfotouh ME, et al. The effectof uterine artery ligation in patients with central placentaprevia: A randomized controlled trial. BMC PregnancyChildbirth 2018; 18: 351. doi:10.1186/s12884-018-1989-5.
Abbas AM, Shady NW, Sallam HF. Bilateral uterine arteryligation plus intravenous tranexamic acid during cesareandelivery for placenta previa: a randomized double-blindcontrolled trial. J Gynecol Obstet Hum Reprod 2019; 48(2): 115-19. doi: 10.1016/j.jogoh.2018.10.023
Erin R, İssak A, Baki Erin K, Kulaksiz D, Bayoğlu TY. The efficiencyof temporary uterine artery ligation on prevention ofthe bleeding in cesarean section. Gynecologic and ObstetricInvestigation 2021; 86 (6): 486-93. doi:10.1159/000519370
Ahmed S, Mohammed KA, Ahmed MA, et al. Randomizedcontrolled trial of the effect of bilateral uterine arteryligation during cesarean among women at risk of uterineatony. Int J Gynecol Obstet 2020; 148: 219-24. doi:10.1002/ijgo.13064